Screening for prostate cancer

 Screening for prostate cancer

Screening for prostate cancer - a survey of men, in order to identify the disease of prostate cancer at an early stage, in which a perhaps the most effective and radical treatments.Low (recovery) care population the world with regard to malignant disease and the lack of investigation are the main causes of late detection of prostate cancer in dalekozashedshey incurable stage.Russia today, more than half of the cases of prostate cancer detected at a stage where almost ineffective treatment administration. The most important for the detection of prostate cancer reason is that in the early stages of prostate cancer clinical signs are absent.This leads to the fact that the vast majority of men go to the doctor only when the various manifestations of the disease. In this sense, the largest value in the early diagnosis of prostate cancer is preventive examinations. In developed countries, the use of these preventive screening led to the identification of the earliest and most curable forms of the disease, reducing the mortality of prostate cancer for more than 3 times. The determination of PSA (prostate specific antigen) test to determine the level of tumor marker for prostate cancer - PSA (prostate specific antigen) in most suspected cases of prostate cancer in an asymptomatic stage of disease. Therefore, determining the level of PSA (prostate specific antigen) is more important than the estimation of the clinical manifestations of the disease indicator. In this sense, determining the level of PSA (prostate specific antigen) should be regular preventive study of men aged 45 to 75 years. DRE prostate Moreover, it is important to remember that the normal level of PSA (prostate specific antigen) does not exclude the presence of prostate cancer. Therefore, the annual preventive care must also include a digital rectal exam (prostate assessment finger is inserted into the rectum). The transrectal ultrasound of the prostate (ETR) of transrectal ultrasound (TRUS) - is an ultrasound of the prostate using a transrectal ultrasound probe special, which is inserted into the rectum studied. This input sensor is located in close proximity to the prostate and is accessible only the rectal wall. Fundamentals of the advantages of transrectal ultrasound of the prostate (ETR) is an opportunity to get a clear picture of the prostate, with a detailed description of its various departments, allowing a well to see the body. Therefore, transrectal ultrasound of the prostate (ETR) is the most accurate for studies of prostate ultrasound in detecting prostate cancer at an early stage of development method. Increased PSA prostate biopsy and the presence of dense areas in the prostate gland (according to digital rectal examination and transrectal ultrasound - ETR) is an indication for prostate biopsy. After 75 years of studies aimed at screening to identify prostate cancer inadequate, due to the slow growth of prostate cancer and a high frequency of complications of surgery and radiotherapy for patients in this age group. In addition, many men do not survive lethal prostate cancer in stage due to the death of other concomitant diseases